Bacteriotherapy ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
96	Crohn disease	1
97	Ulcerative colitis	2

96. Crohn disease

Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01757964 (ClinicalTrials.gov)	December 2012	22/12/2012	Bacteriotherapy in Pediatric Inflammatory Bowel Disease	Bacteriotherapy in Pediatric Inflammatory Bowel Disease	Inflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis;CD	Biological: Bacteriotherapy	David Suskind	Seattle Children's Hospital	Completed	12 Years	21 Years	All	13	Phase 1	United States

Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03104036 (ClinicalTrials.gov)	June 19, 2017	27/3/2017	Faecal Bacteriotherapy for Ulcerative Colitis	Faecal Bacteriotherapy for Ulcerative Colitis	Ulcerative Colitis	Other: Faecal bacterial transplantation;Drug: Mesalazine 4G Enema	Institute for Clinical and Experimental Medicine	Institute of Animal Physiology and Genetics Academy of Science Czech Republic	Completed	18 Years	70 Years	All	61	Phase 2	Czechia;Czech Republic
2	NCT01757964 (ClinicalTrials.gov)	December 2012	22/12/2012	Bacteriotherapy in Pediatric Inflammatory Bowel Disease	Bacteriotherapy in Pediatric Inflammatory Bowel Disease	Inflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis;CD	Biological: Bacteriotherapy	David Suskind	Seattle Children's Hospital	Completed	12 Years	21 Years	All	13	Phase 1	United States